NDC 63090-340

NUPLAZID

Pimavanserin Tartrate

NUPLAZID is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Acadia Pharmaceuticals In. The primary component is Pimavanserin Ta.

• Product ID: 63090-340_0f0dfb31-4001-49c0-8b2d-c281e6872260
• NDC: 63090-340
• Product Type: Human Prescription Drug
• Proprietary Name: NUPLAZID
• Generic Name: Pimavanserin Tartrate
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2018-06-28
• Marketing Category: NDA / NDA
• Application Number: NDA210793
• Labeler Name: ACADIA Pharmaceuticals In
• Substance Name: PIMAVANSERIN TA
• Active Ingredient Strength: 34 mg/1
• Pharm Classes: Atypical Antips
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 63090-340-30

30 CAPSULE in 1 BOTTLE, PLASTIC (63090-340-30)

• Marketing Start Date: 2018-06-28
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63090-340-30 [63090034030]

NUPLAZID CAPSULE

• Marketing Category: NDA
• Application Number: NDA210793
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-06-28

Drug Details

Active Ingredients

Ingredient	Strength
PIMAVANSERIN TARTRATE	34 mg/1

OpenFDA Data

• SPL SET ID: 1e6bea44-57d6-4bac-9328-46e1ee59f83b
• Manufacturer:
  • ACADIA Pharmaceuticals Inc
• UNII:
  • NA83F1SJSR
• RxNorm Concept Unique ID - RxCUI:
  • 1791691
  • 2049269
  • 2049278
  • 1791697
  • 2049275
  • 2049271
• UPC Code:
  • 0363090340303
  • 0363090170603
  • 0363090100303

Pharmacological Class

• Atypical Antipsychotic [EPC]

NDC Crossover Matching brand name "NUPLAZID" or generic name "Pimavanserin Tartrate"

NDC	Brand Name	Generic Name
63090-100	NUPLAZID	pimavanserin tartrate
63090-170	NUPLAZID	pimavanserin tartrate
63090-340	NUPLAZID	pimavanserin tartrate